EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking

Priyanka Mangla, Quentin Vicentini, Annabelle Biscans iD

Cells · 11.09.2023 · 12 (18) · 2253

DOI: 10.3390/cells12182253 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 11.09.2023. Verfasst von Priyanka Mangla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oligonucleotide Discovery, Discovery Sciences Research and Development, AstraZeneca, 431 38 Gothenburg, Sweden. Hauptthemen laut MEDLINE: Endosomes, Central Nervous System. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 283 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potential of oligonucleotide therapeutics is undeniable as more than 15 drugs have been approved to treat various diseases in the liver, central nervous system (CNS), and muscles. However, achieving effective delivery of oligonucleotide therapeutics to specific tissues still remains a major challenge, limiting their widespread use. Chemical modifications play a crucial role to overcome biological barriers to enable efficient oligonucleotide delivery to the tissues/cells of interest. They provide oligonucleotide metabolic stability and confer favourable pharmacokinetic/pharmacodynamic properties. This review focuses on the various chemical approaches implicated in mitigating the delivery problem of oligonucleotides and their limitations. It highlights the importance of linkers in designing oligonucleotide conjugates and discusses their potential role in escaping the endosomal barrier, a bottleneck in the development of oligonucleotide therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndosomesCentral Nervous SystemLiverMusclesOligonucleotides

Stichwörter der Autor:innen

antisense oligonucleotides (ASOs)cleavable linkersendosomal escapeendosomolytic agentslinker chemistrynon-cleavable linkersoligonucleotide conjugatesoligonucleotide deliveryoligonucleotide therapeuticspH-sensitive linkerssiRNA

Substanzen

Oligonucleotides

Autor:innen und Institutionen

  • Oligonucleotide Discovery, Discovery Sciences Research and Development, AstraZeneca, 431 38 Gothenburg, Sweden.
  • Department of Laboratory Medicine, Clinical Research Centre, Karolinska Institute, 141 57 Stockholm, Sweden.

ORCID-Profile: Annabelle Biscans

Förderung

  • European Commission

Zitieren

APA

Mangla, P., Vicentini, Q., & Biscans, A. (2023). Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking. Cells, 12(18), 2253. https://doi.org/10.3390/cells12182253

Vancouver

Mangla P, Vicentini Q, Biscans A. Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking. Cells. 2023;12(18):2253. doi:10.3390/cells12182253

BibTeX
@article{Mangla2023,
  author = {Mangla, Priyanka and Vicentini, Quentin and Biscans, Annabelle},
  title = {Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {18},
  pages = {2253},
  doi = {10.3390/cells12182253}
}
Kostenlos starten →